Further studies will be needed to determine the individual impact of CD103 on their function in vivo for the control of development of psoriasiform dermatitis by creating Cd103flox/flox mice to analyze cDC- or CD8+ T cell-specific CD103-ablation in mice. This evidence concerns the gene CD8A and Psoriasiform dermatitis.